Global and Japan Parkinson's Disease Therapeutics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Medications Therapeutics
1.2.3 Medical Devices Therapeutics
1.3 Market by Application
1.3.1 Global Parkinson's Disease Therapeutics Market Share by Application: 2020 VS 2026
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Parkinson's Disease Therapeutics Market Perspective (2015-2026)
2.2 Global Parkinson's Disease Therapeutics Growth Trends by Regions
2.2.1 Parkinson's Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Parkinson's Disease Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Parkinson's Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson's Disease Therapeutics Players by Market Size
3.1.1 Global Top Parkinson's Disease Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Players (2015-2020)
3.2 Global Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Parkinson's Disease Therapeutics Revenue
3.4 Global Parkinson's Disease Therapeutics Market Concentration Ratio
3.4.1 Global Parkinson's Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Therapeutics Revenue in 2019
3.5 Key Players Parkinson's Disease Therapeutics Area Served
3.6 Key Players Parkinson's Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Parkinson's Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson's Disease Therapeutics Breakdown Data by Type (2015-2026)
4.1 Global Parkinson's Disease Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2021-2026)
5 Parkinson's Disease Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Parkinson's Disease Therapeutics Historic Market Size by Application (2015-2020)
5.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Parkinson's Disease Therapeutics Market Size (2015-2026)
6.2 North America Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
6.3 North America Parkinson's Disease Therapeutics Market Size by Application (2015-2020)
6.4 North America Parkinson's Disease Therapeutics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Parkinson's Disease Therapeutics Market Size (2015-2026)
7.2 Europe Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
7.3 Europe Parkinson's Disease Therapeutics Market Size by Application (2015-2020)
7.4 Europe Parkinson's Disease Therapeutics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Parkinson's Disease Therapeutics Market Size (2015-2026)
8.2 China Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
8.3 China Parkinson's Disease Therapeutics Market Size by Application (2015-2020)
8.4 China Parkinson's Disease Therapeutics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Parkinson's Disease Therapeutics Market Size (2015-2026)
9.2 Japan Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
9.3 Japan Parkinson's Disease Therapeutics Market Size by Application (2015-2020)
9.4 Japan Parkinson's Disease Therapeutics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Parkinson's Disease Therapeutics Market Size (2015-2026)
10.2 Southeast Asia Parkinson's Disease Therapeutics Market Size by Type (2015-2020)
10.3 Southeast Asia Parkinson's Disease Therapeutics Market Size by Application (2015-2020)
10.4 Southeast Asia Parkinson's Disease Therapeutics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Parkinson's Disease Therapeutics Introduction
11.1.4 GSK Revenue in Parkinson's Disease Therapeutics Business (2015-2020))
11.1.5 GSK Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Parkinson's Disease Therapeutics Introduction
11.2.4 Novartis Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
11.2.5 Novartis Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Introduction
11.3.4 Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Details
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Introduction
11.4.4 Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
11.4.5 Teva Pharmaceutical Recent Development
11.5 Abbvie
11.5.1 Abbvie Company Details
11.5.2 Abbvie Business Overview
11.5.3 Abbvie Parkinson's Disease Therapeutics Introduction
11.5.4 Abbvie Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
11.5.5 Abbvie Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Parkinson's Disease Therapeutics Introduction
11.6.4 Merck Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
11.6.5 Merck Recent Development
11.7 Akorn
11.7.1 Akorn Company Details
11.7.2 Akorn Business Overview
11.7.3 Akorn Parkinson's Disease Therapeutics Introduction
11.7.4 Akorn Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
11.7.5 Akorn Recent Development
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Details
11.8.2 Kyowa Hakko Kirin Pharma Business Overview
11.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Introduction
11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
11.8.5 Kyowa Hakko Kirin Pharma Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Parkinson's Disease Therapeutics Introduction
11.9.4 Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
11.9.5 Astellas Pharma Recent Development
11.10 Desitin Arzneimittel
11.10.1 Desitin Arzneimittel Company Details
11.10.2 Desitin Arzneimittel Business Overview
11.10.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Introduction
11.10.4 Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
11.10.5 Desitin Arzneimittel Recent Development
11.11 Endo Pharmaceuticals
10.11.1 Endo Pharmaceuticals Company Details
10.11.2 Endo Pharmaceuticals Business Overview
10.11.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Introduction
10.11.4 Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
10.11.5 Endo Pharmaceuticals Recent Development
11.12 F.Hoffmann-La Roche
10.12.1 F.Hoffmann-La Roche Company Details
10.12.2 F.Hoffmann-La Roche Business Overview
10.12.3 F.Hoffmann-La Roche Parkinson's Disease Therapeutics Introduction
10.12.4 F.Hoffmann-La Roche Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
10.12.5 F.Hoffmann-La Roche Recent Development
11.13 H.Lundbeck
10.13.1 H.Lundbeck Company Details
10.13.2 H.Lundbeck Business Overview
10.13.3 H.Lundbeck Parkinson's Disease Therapeutics Introduction
10.13.4 H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
10.13.5 H.Lundbeck Recent Development
11.14 Valeant
10.14.1 Valeant Company Details
10.14.2 Valeant Business Overview
10.14.3 Valeant Parkinson's Disease Therapeutics Introduction
10.14.4 Valeant Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
10.14.5 Valeant Recent Development
11.15 Apokyn
10.15.1 Apokyn Company Details
10.15.2 Apokyn Business Overview
10.15.3 Apokyn Parkinson's Disease Therapeutics Introduction
10.15.4 Apokyn Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
10.15.5 Apokyn Recent Development
11.16 Orion
10.16.1 Orion Company Details
10.16.2 Orion Business Overview
10.16.3 Orion Parkinson's Disease Therapeutics Introduction
10.16.4 Orion Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
10.16.5 Orion Recent Development
11.17 Stada Arzneimittel
10.17.1 Stada Arzneimittel Company Details
10.17.2 Stada Arzneimittel Business Overview
10.17.3 Stada Arzneimittel Parkinson's Disease Therapeutics Introduction
10.17.4 Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
10.17.5 Stada Arzneimittel Recent Development
11.18 US WorldMeds
10.18.1 US WorldMeds Company Details
10.18.2 US WorldMeds Business Overview
10.18.3 US WorldMeds Parkinson's Disease Therapeutics Introduction
10.18.4 US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
10.18.5 US WorldMeds Recent Development
11.19 Bausch Health
10.19.1 Bausch Health Company Details
10.19.2 Bausch Health Business Overview
10.19.3 Bausch Health Parkinson's Disease Therapeutics Introduction
10.19.4 Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2015-2020)
10.19.5 Bausch Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Medications Therapeutics
Table 4. Key Players of Medical Devices Therapeutics
Table 5. Global Parkinson's Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Parkinson's Disease Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Parkinson's Disease Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Parkinson's Disease Therapeutics Market Share by Regions (2015-2020)
Table 9. Global Parkinson's Disease Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Parkinson's Disease Therapeutics Market Share by Regions (2021-2026)
Table 11. Parkinson's Disease Therapeutics Market Market Trends
Table 12. Parkinson's Disease Therapeutics Market Drivers
Table 13. Parkinson's Disease Therapeutics Market Challenges
Table 14. Parkinson's Disease Therapeutics Market Restraints
Table 15. Global Parkinson's Disease Therapeutics Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Parkinson's Disease Therapeutics Market Share by Players (2015-2020)
Table 17. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Therapeutics as of 2019)
Table 18. Global Parkinson's Disease Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Parkinson's Disease Therapeutics Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Parkinson's Disease Therapeutics Market Size Share by Type (2015-2020)
Table 24. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2021-2026)
Table 25. Global Parkinson's Disease Therapeutics Market Size Share by Application (2015-2020)
Table 26. Global Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Parkinson's Disease Therapeutics Market Size Share by Application (2021-2026)
Table 28. North America Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Parkinson's Disease Therapeutics Market Share by Type (2015-2020)
Table 30. North America Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Parkinson's Disease Therapeutics Market Share by Application (2015-2020)
Table 32. North America Parkinson's Disease Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Parkinson's Disease Therapeutics Market Share by Country (2015-2020)
Table 34. Europe Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Parkinson's Disease Therapeutics Market Share by Type (2015-2020)
Table 36. Europe Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Parkinson's Disease Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Parkinson's Disease Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Parkinson's Disease Therapeutics Market Share by Country (2015-2020)
Table 40. China Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 41. China Parkinson's Disease Therapeutics Market Share by Type (2015-2020)
Table 42. China Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 43. China Parkinson's Disease Therapeutics Market Share by Application (2015-2020)
Table 44. China Parkinson's Disease Therapeutics Market Size by Region (US$ Million) (2015-2020)
Table 45. China Parkinson's Disease Therapeutics Market Share by Region (2015-2020)
Table 46. Japan Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Parkinson's Disease Therapeutics Market Share by Type (2015-2020)
Table 48. Japan Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Parkinson's Disease Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Parkinson's Disease Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Parkinson's Disease Therapeutics Market Share by Country (2015-2020)
Table 52. Southeast Asia Parkinson's Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Parkinson's Disease Therapeutics Market Share by Type (2015-2020)
Table 54. Southeast Asia Parkinson's Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Parkinson's Disease Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Parkinson's Disease Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Parkinson's Disease Therapeutics Market Share by Country (2015-2020)
Table 58. GSK Company Details
Table 59. GSK Business Overview
Table 60. GSK Product
Table 61. GSK Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 62. GSK Recent Development
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Product
Table 66. Novartis Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 67. Novartis Recent Development
Table 68. Boehringer Ingelheim Company Details
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim Product
Table 71. Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 72. Boehringer Ingelheim Recent Development
Table 73. Teva Pharmaceutical Company Details
Table 74. Teva Pharmaceutical Business Overview
Table 75. Teva Pharmaceutical Product
Table 76. Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 77. Teva Pharmaceutical Recent Development
Table 78. Abbvie Company Details
Table 79. Abbvie Business Overview
Table 80. Abbvie Product
Table 81. Abbvie Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 82. Abbvie Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Product
Table 86. Merck Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 87. Merck Recent Development
Table 88. Akorn Company Details
Table 89. Akorn Business Overview
Table 90. Akorn Product
Table 91. Akorn Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 92. Akorn Recent Development
Table 93. Kyowa Hakko Kirin Pharma Business Overview
Table 94. Kyowa Hakko Kirin Pharma Product
Table 95. Kyowa Hakko Kirin Pharma Company Details
Table 96. Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 97. Kyowa Hakko Kirin Pharma Recent Development
Table 98. Astellas Pharma Company Details
Table 99. Astellas Pharma Business Overview
Table 100. Astellas Pharma Product
Table 101. Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 102. Astellas Pharma Recent Development
Table 103. Desitin Arzneimittel Company Details
Table 104. Desitin Arzneimittel Business Overview
Table 105. Desitin Arzneimittel Product
Table 106. Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 107. Desitin Arzneimittel Recent Development
Table 108. Endo Pharmaceuticals Company Details
Table 109. Endo Pharmaceuticals Business Overview
Table 110. Endo Pharmaceuticals Product
Table 111. Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 112. Endo Pharmaceuticals Recent Development
Table 113. F.Hoffmann-La Roche Company Details
Table 114. F.Hoffmann-La Roche Business Overview
Table 115. F.Hoffmann-La Roche Product
Table 116. F.Hoffmann-La Roche Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 117. F.Hoffmann-La Roche Recent Development
Table 118. H.Lundbeck Company Details
Table 119. H.Lundbeck Business Overview
Table 120. H.Lundbeck Product
Table 121. H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 122. H.Lundbeck Recent Development
Table 123. Valeant Company Details
Table 124. Valeant Business Overview
Table 125. Valeant Product
Table 126. Valeant Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 127. Valeant Recent Development
Table 128. Apokyn Company Details
Table 129. Apokyn Business Overview
Table 130. Apokyn Product
Table 131. Apokyn Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 132. Apokyn Recent Development
Table 133. Orion Company Details
Table 134. Orion Business Overview
Table 135. Orion Product
Table 136. Orion Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 137. Orion Recent Development
Table 138. Stada Arzneimittel Company Details
Table 139. Stada Arzneimittel Business Overview
Table 140. Stada Arzneimittel Product
Table 141. Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 142. Stada Arzneimittel Recent Development
Table 143. US WorldMeds Company Details
Table 144. US WorldMeds Business Overview
Table 145. US WorldMeds Product
Table 146. US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 147. US WorldMeds Recent Development
Table 148. Bausch Health Company Details
Table 149. Bausch Health Business Overview
Table 150. Bausch Health Product
Table 151. Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2015-2020) (US$ Million)
Table 152. Bausch Health Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Parkinson's Disease Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Medications Therapeutics Features
Figure 3. Medical Devices Therapeutics Features
Figure 4. Global Parkinson's Disease Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Under 40 Years Old Case Studies
Figure 6. 40-65 Years Old Case Studies
Figure 7. Above 65 Years Old Case Studies
Figure 8. Parkinson's Disease Therapeutics Report Years Considered
Figure 9. Global Parkinson's Disease Therapeutics Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Parkinson's Disease Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Parkinson's Disease Therapeutics Market Share by Regions (2021-2026)
Figure 12. Global Parkinson's Disease Therapeutics Market Share by Players in 2019
Figure 13. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Therapeutics as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Parkinson's Disease Therapeutics Revenue in 2019
Figure 15. North America Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Rest of Europe Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa Parkinson's Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. GSK Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 43. Novartis Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 44. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 45. Teva Pharmaceutical Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 46. Abbvie Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 47. Merck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 48. Akorn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 49. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 50. Astellas Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 51. Desitin Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 52. Endo Pharmaceuticals Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 53. F.Hoffmann-La Roche Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 54. H.Lundbeck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 55. Valeant Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 56. Apokyn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 57. Orion Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 58. Stada Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 59. US WorldMeds Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 60. Bausch Health Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2015-2020)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed